Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9329 |
High Similarity |
NPD2801 |
Approved |
0.9262 |
High Similarity |
NPD1934 |
Approved |
0.898 |
High Similarity |
NPD1511 |
Approved |
0.8947 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8859 |
High Similarity |
NPD1512 |
Approved |
0.8831 |
High Similarity |
NPD3882 |
Suspended |
0.8679 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8679 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8679 |
High Similarity |
NPD6166 |
Phase 2 |
0.8571 |
High Similarity |
NPD3818 |
Discontinued |
0.8544 |
High Similarity |
NPD5494 |
Approved |
0.8514 |
High Similarity |
NPD1549 |
Phase 2 |
0.8471 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8466 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8446 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8446 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8424 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8408 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8408 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8405 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8356 |
Intermediate Similarity |
NPD447 |
Suspended |
0.8354 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8344 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8311 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8301 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8288 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8288 |
Intermediate Similarity |
NPD943 |
Approved |
0.8269 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8264 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8194 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8193 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8187 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8187 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8163 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8163 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8148 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8144 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8133 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8113 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8098 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8095 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8072 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8061 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8013 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8013 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7987 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7976 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7962 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7949 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7949 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7929 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7922 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7875 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7867 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7843 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.784 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7831 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7826 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7812 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7808 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7806 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7805 |
Intermediate Similarity |
NPD919 |
Approved |
0.7799 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7792 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.775 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7744 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7718 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7712 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7711 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7683 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7628 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7625 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7614 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7603 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7597 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7588 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7584 |
Intermediate Similarity |
NPD9494 |
Approved |
0.758 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7574 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7548 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7516 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD920 |
Approved |
0.75 |
Intermediate Similarity |
NPD2344 |
Approved |
0.75 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7434 |
Intermediate Similarity |
NPD411 |
Approved |
0.7432 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.743 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7429 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7417 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7415 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7405 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7405 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.74 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7391 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7391 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7391 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7372 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7358 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7353 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7345 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7312 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7303 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7297 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7294 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7289 |
Intermediate Similarity |
NPD37 |
Approved |
0.7283 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7267 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7262 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7262 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.726 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7257 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7255 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7248 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7248 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7219 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7209 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7208 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7181 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7171 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD5019 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7134 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7124 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7119 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7117 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7111 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7111 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.711 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7108 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7079 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7079 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7075 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7074 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7073 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7073 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7073 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7051 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7047 |
Intermediate Similarity |
NPD17 |
Approved |
0.7044 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7037 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7024 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7014 |
Intermediate Similarity |
NPD228 |
Approved |
0.7013 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7012 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7007 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7 |
Intermediate Similarity |
NPD5353 |
Approved |
0.6993 |
Remote Similarity |
NPD3267 |
Approved |
0.6993 |
Remote Similarity |
NPD3266 |
Approved |
0.6987 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6987 |
Remote Similarity |
NPD3764 |
Approved |
0.6987 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD9268 |
Approved |
0.6975 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6971 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD2899 |
Discontinued |
0.6957 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6957 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6954 |
Remote Similarity |
NPD5710 |
Approved |
0.6954 |
Remote Similarity |
NPD5711 |
Approved |
0.6954 |
Remote Similarity |
NPD1535 |
Discovery |
0.6947 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6947 |
Remote Similarity |
NPD7698 |
Approved |
0.6947 |
Remote Similarity |
NPD7697 |
Approved |
0.6928 |
Remote Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.6923
|
Remote Similarity |
NPD6386 |
Approved |